Search
Menu
Home
HTB
2010
October
HTB
October 2010
Contents
Conference reports
50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 12-15 September 2010, Boston
Raltegravir pharmacokinetics inpregnancy
Low birth weight associated with HAART in pregnancy in Zambia
Bilirubin levels in infants following in utero atazanavir exposure compared to exposure to other antiretrovirals
Novel mutations and shifting susceptibility to darunavir and tipranavir
Four-drug single-pill antiretroviral equivalent to Atripla at 48 weeks
High rates of bone loss and progression with HIV in longitudinal study
XVIII International AIDS Conference: 18-23 July 2010, Vienna
Spray-dried nanoparticle formulation of efavirenz
Switching boosted-PIs to raltegravir
Scaling up: what to do first?
A new point of care CD4 test
Early infant diagnosis
Efavirenz-based regimens among womenof reproductive age receiving ART in Johannesburg
Male circumcision retains effectiveness at reducing risk of HIV infection: 54 month results
Towards a cure: HIV reservoirs and strategies to control them, 16–17 July 2010, Vienna
Rapporteur summaries
Antiretrovirals
START study given green light for full study
Saquinavir prolongation of QT interval: Rocheissue Dear Doctor letter
Development of chronic kidney disease and antiretroviral use in EuroSIDA cohortsince 2004
Treatment access
FDA approval of generic ARVs
IAS highlight funding shortfall crisis for Global Fund
The need for expanded access to experimental medicines for drug-resistant TB
Indian activists challenge proposed EU tradeagreements: Global access to Indian generic ARVs threatened
Russian HIV activists arrested in Red Square for protesting drug stock-outs
Chinese HIV positive activist Tian Xi to go on trial on trumped up charges
US waiting lists increase by over 300% in five months
Women's health
HPV-based screen-and-treat is effective for cervical cancer prevention in HIV-positive women
Genital tract viral load in women with below detectable plasma viral load
Pregnancy
Test and treat for all pregnant women in low and middle income countries?
Retrospective analysis finds higher prevalence of birth defects associated with efavirenz than previously reported
Paediatric care
US paediatric guidelines updated (August 2010)
Daily cotrimoxazole preferable to intermittent preventative therapy inHIV-infected children
Guidelines
BHIVA monitoring guidelines online for comment (2010)
Side effects
Tesamorelin for reduction of central fat accumulation: regulatory decision delayed in the US
Basic science and immunology
Signs of progress in gene therapy for HIV
PDFs
Volume 11Number 9/10 September/October 2010 PDF
HTB RSS
Current issues
October 2024
September 2024
August 2024
Back issues
Special report
HIV diagnoses in England jump by 51% in 2023: missing targets and highlighting disparities in access to care
6 October 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage